TORONTO, ON–(Marketwired – Jan 23, 2017) – Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) Announces that it has signed a letter of intent to acquire 100% of revenue producing vaporizer manufacturer iBliss Inc., of Toronto, Ontario, Canada.
Revenue Projections Could Dwarf Britain’s Expected $10 Million per Year Due to Many Times Higher Birth Rates in Latin America
TORONTO, ON–(Marketwired – Aug 4, 2015) – Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces Easton and BMV have signed an agreement and made a payment to Common Sense LTD. of Israel for the exclusive rights to market and sell Common Sense’s AL-Sense (Amniotic-Sense-Blue) Amniotic Fluid Leak Test for most of Latin America.
Continue reading Easton Pharmaceuticals and BMV Medica Finalize License Agreement With CommonSense Ltd. of Israel to Be Sole Distributor for Patented AL-Sense (Amnio-Sense-Blue) Amniotic Fluid Leak Test for Latin America
TORONTO, ON–(Marketwired – Jul 29, 2015) – Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces the appointment of Evan Karras as CEO & Director and announces Mr. Nunzio Valerie as President and Director.
Continue reading Easton Pharmaceuticals Announces the Appointment of Evan Karras as CEO / Director and Mr. Nunzio Valerie as President / CFO; Mr. Karras Possesses a Strong Background in Canadian and International Commercial Successes and Is Expected to Make Major Impact on Implementation of Easton’s Business Plan
TORONTO, ON–(Marketwired – Jul 6, 2015) – Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces positive update from Ackerman Pharma; where the regulatory filing and anticipated approval process for the cancer drugs Paclitaxel and Docetaxel has been shortened.
Continue reading Easton Pharmaceuticals / BMV Medica Announces Its Mexican Ministry of Health and Latin America Regulatory Filing and Approval Process for Cancer Drugs Paclitaxel and Docetaxel From Biolyse Pharma Has Been Shortened
TORONTO, ON–(Marketwired – Jun 23, 2015) – Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces that Easton and BMV have decided on Eva Pro as brand name for its line of patented women’s diagnostic tests for Mexico and possibly the Latin American market. The Eva Pro brand will include both the already secured vaginal infection diagnostic test and most likely the amniotic fluid leak test for late pregnancy. Easton / BMV move toward Trademarking and provides update on Latin American market.
Continue reading Easton Pharmaceuticals and BMV Medica Announce Eva Pro as Brand Name for Its Line of Patented Women’s Diagnostic Tests for the Mexican and Other Latin American Markets; Trademark Registration of Individual Product Names, Logos and Packaging Has Commenced
The VS-Sense Diagnostic Product Line Currently Holds Extended Patent Protection and Is Expected to Generate Well Over 100% Profit Margins for Easton / BMV; The Vaginal Health Test Is Currently Sold throughout the United States, Canada and Soon Europe.
Continue reading Easton Pharmaceuticals Announces Finalized Joint Partnership Agreement With BMV Medica for Exclusive Rights to Distribute World Patented Women’s Health Diagnostic Test in Mexico From Israel-Based Common Sense Ltd.
TORONTO, ON–(Marketwired – Dec 31, 2014) – Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces it has signed an agreement with Medicated Markets International LLC., a major California medical marijuana grower.
TORONTO, ON–(Marketwired – Mar 11, 2014) – Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it nearing its limit on financing under regulation offerings.